机译:不同阶段的男性导管和小叶乳腺癌患者的存活分析
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 2 277 West Yanta Rd Xian 710061;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Radiat Oncol 277 West Yanta Rd Xian 710061 Shaanxi;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 2 277 West Yanta Rd Xian 710061;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Operat Management 277 West Yanta Rd Xian 710061;
Xi An Jiao Tong Univ Affiliated Hosp 2 Dept Oncol 157 West Fifth St Xian 710004 Shaanxi;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 2 277 West Yanta Rd Xian 710061;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 277 West Yanta Rd Xian 710061 Shaanxi;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 2 277 West Yanta Rd Xian 710061;
Xi An Jiao Tong Univ Affiliated Hosp 1 Dept Thorac Surg 277 West Yanta Rd Xian 710061 Shaanxi;
ER; HER-2; male breast cancer; metastasis sites; nomograms; PR; prognosis;
机译:不同阶段的男性导管和小叶乳腺癌患者的存活分析
机译:浸润性导管癌和浸润性小叶乳腺癌患者之间的生存分析
机译:侵袭性导管患者患者生存分析及侵袭性小叶乳腺癌。
机译:弥散加权成像(DWI)用于挑战性导管原位癌(DCIS)和侵袭性小叶癌(ILC)的乳腺癌
机译:早期乳腺癌和合并症:种族对乳腺癌无病生存率差异的影响。
机译:侵袭性小叶侵袭性导管和混合侵袭性导管和小叶乳腺癌的临床病理特征转移部位和生存结果的比较
机译:表5.5.a.1肿瘤大小和治疗(重新切性率)图5.5.a.2根据残留肿瘤对TS1癌胰腺切除后患者的累积存活图5.5.A.3累积存活根据淋巴结解剖的程度,TS1癌症的患者图5.5.A.4在胰头胰腺IIA或IIB癌症术后胰岛切除术后的门静脉和累积患者的累积存活图5.5。 A.5在胰头术后IIA或IIB胰腺切除术后,患者胰腺癌丛和患者累积存活的组合图5.5.A.6当没有丛浸润时,围裙丛生的围嘴巴丛的切除胰腺切除术后胰腺切除术后胰腺炎癌症的累积存活图5.5.A.7在TS1癌症胰腺切除后患者的动脉和累积存活的组合UICC阶段IIA或IIB在胰头图5.5.A.8在胰头胰腺阶段IIA或IIB癌症的胰腺切除后,患者的门静脉和累积患者的累积存活率图5.5.A.9在胰头胰腺阶段IIA或IIB的胰腺切除术后胰腺切除术后患者患者患者患者的累积生存的组合和胰腺头
机译:基因组广泛检查小叶和乳腺癌的等位基因丢失